Dr Fawzy - Textured Background

Sleep Apnea

Dr Tamer Fawzy - Sleep Apnea Landing

Dr. Tamer Fawzy is a Consultant ENT and Sleep Surgeon specializing in the diagnosis and advanced management of snoring and obstructive sleep apnea.

His approach combines modern sleep medicine, precise airway evaluation, metabolic optimization, and contemporary surgical techniques to deliver personalized long‑term solutions.

Dr Tamer Fawzy - Sleep Apnea Landing

Understanding Obstructive Sleep Apnea

Obstructive Sleep Apnea (OSA) is a disorder in which breathing repeatedly becomes shallow or stops during sleep due to collapse of the upper airway. These events reduce oxygen levels, disrupt normal sleep cycles, and place significant strain on the cardiovascular system.

Symptoms

Loud snoring

Choking during sleep

Restless sleep

Daytime fatigue

Morning headaches

Poor concentration

Memory difficulties

Irritability

Reduced work performance

Health Risks

Untreated sleep apnea is linked to hypertension, heart disease, stroke, metabolic syndrome, type 2 diabetes, and reduced quality of life.

Risk Factors and BMI

Body Mass Index (BMI) is an important indicator of risk. Increased weight contributes to fatty tissue deposition around the airway, increasing its tendency to collapse. However, anatomical factors such as jaw position, tongue size, and palatal structure can cause OSA even in normal‑weight individuals.

Diagnosis

Diagnosis involves clinical evaluation and sleep testing. Polysomnography measures breathing events, oxygen levels, sleep stages, and heart rhythm. The Apnea‑Hypopnea Index (AHI) determines disease severity.

Wearable devices may assist screening but cannot replace formal sleep studies.

Polysomnography (Sleep Study)

Polysomnography, commonly known as a sleep study, is the most reliable method for diagnosing obstructive sleep apnea and many other sleep disorders. During the study, multiple physiological parameters are recorded including brain activity, breathing effort, airflow, oxygen saturation, heart rhythm, body position, and limb movements. This detailed monitoring allows physicians to evaluate sleep structure and breathing stability throughout the night.

A key outcome of the sleep study is the Apnea-Hypopnea Index (AHI). This value represents the number of breathing interruptions per hour of sleep. An AHI of 5–15 is generally classified as mild sleep apnea, 15–30 as moderate, and greater than 30 as severe. The AHI plays a central role in determining the most appropriate treatment strategy. For example, mild disease may be managed with lifestyle measures or oral appliances, while moderate to severe sleep apnea often requires CPAP therapy or advanced surgical evaluation.

Dr Fawzy - Textured BackgroundDr Fawzy Preocedures Background

Frequently asked questions

Not always, but it should be evaluated.

Some patients achieve long‑term improvement with weight loss or surgery.

No. Multiple options exist depending on the patient.

Home vs In-Lab Sleep Study

In-lab polysomnography is considered the gold standard because it provides comprehensive monitoring and direct technical supervision. It is particularly useful for patients with complex medical conditions or unclear symptoms. Home sleep apnea testing offers a convenient alternative for selected patients with a high likelihood of obstructive sleep apnea and no major comorbidities. However, home studies typically record fewer signals and may underestimate disease severity in some cases.

Sleep Endoscopy

Drug‑Induced Sleep Endoscopy allows visualization of airway collapse patterns and supports accurate surgical planning.

Non‑Surgical Treatment

CPAP therapy remains highly effective when tolerated. Custom dental appliances may help selected patients by advancing the lower jaw. Weight reduction and GLP‑1 medications can improve disease severity in obese patients

CPAP Therapy

Continuous Positive Airway Pressure (CPAP) therapy remains one of the most effective treatments for moderate to severe obstructive sleep apnea. The device delivers pressurized air through a mask worn during sleep, helping to keep the airway open and prevent breathing interruptions.

By stabilizing breathing patterns, CPAP improves oxygen levels and allows patients to achieve deeper, more restorative sleep stages. Many individuals experience reduced snoring, improved daytime alertness, and better cardiovascular health when therapy is used consistently. Modern CPAP devices can automatically adjust pressure levels and include humidification features to improve comfort and adherence.

Despite its effectiveness, some patients find CPAP challenging due to mask discomfort, dryness, or pressure sensation. In such cases, specialist follow-up is important to optimize mask selection, pressure settings, and treatment education.

Oral Appliance Therapy

Oral appliance therapy is a well-established treatment option for selected patients with obstructive sleep apnea, particularly those with mild to moderate disease or individuals who cannot tolerate CPAP therapy. These custom-made dental devices work by gently advancing the lower jaw forward during sleep, which increases airway space behind the tongue and reduces airway collapse.

The decision to use an oral appliance is influenced by factors such as AHI severity, body weight, airway anatomy, and patient preference. While oral appliances may not fully eliminate breathing disturbances in severe cases, they can significantly reduce symptoms and improve sleep quality in appropriately selected individuals.

Successful therapy requires careful fitting by trained dental sleep professionals and follow-up sleep testing to confirm effectiveness. When integrated into a comprehensive treatment plan that may include weight management or airway evaluation, oral appliance therapy can play an important role in personalized sleep apnea care.

GLP-1 Medications ( Ozempic / Munjaro / Wegovy )

A New Approach to Metabolic Treatment in OSA

GLP-1 receptor agonists are emerging as an important addition to the treatment of obstructive sleep apnea (OSA), particularly in patients with overweight or obesity. These medications work by regulating appetite, improving insulin sensitivity, and promoting significant weight loss. Because excess weight is a major contributor to airway narrowing, reducing body fat can help decrease upper airway collapse during sleep.

Clinical evidence shows that weight loss achieved with GLP-1–based therapy can lead to measurable improvements in the Apnea-Hypopnea Index (AHI), a key indicator used to assess sleep apnea severity. In 2024, regulatory approval of tirzepatide for adults with moderate to severe OSA and obesity ( BMI above 30) marked an important step in recognizing the role of metabolic treatment in sleep medicine.

However, GLP-1 therapy is not a standalone solution. It does not directly correct anatomical airway obstruction and should be used as part of a comprehensive treatment plan. This may include sleep studies, CPAP therapy, oral appliances, or surgical evaluation depending on individual patient needs.

When used appropriately under medical supervision, GLP-1 medications can support long-term weight management, improve sleep quality, and enhance overall cardiometabolic health.

Surgical Treatment

Tonsillectomy improves airway space in selected patients. Palatal surgery (UPPP) reshapes throat tissues. Tongue base surgery addresses obstruction behind the tongue. Hypoglossal nerve stimulation is an implantable therapy that activates tongue muscles during sleep.

Personalized Multilevel Treatment

Modern sleep apnea care requires individualized planning based on anatomy, sleep study findings, metabolic health, and patient preference.

Dr Tamer Fawzy - Ready to Schedule Your Consultation?Dr Tamer Fawzy - Ready to Schedule Your Consultation?

Ready to Schedule Your Consultation?

Sleep Apnea is highly treatable, with accurate diagnosis and targeted treatment, most patients experience significant improvement and a return to their normal daily life.